Article
Somatic alterations of targetable oncogenes are frequently observed in BRCA1/2 mutation negative male breast cancers.
Oncotarget - 8 Nov 2016
Rizzolo Piera, Navazio Anna Sara, Silvestri Valentina, Valentini Virginia, Zelli Veronica, Zanna Ines, Masala Giovanna, Bianchi Simonetta, Scarnò Marco, Tommasi Stefania, Palli Domenico, Ottini Laura
Abstract excerpt
Male breast cancer (MBC) is a rare disease. Due to its rarity, MBC research and clinical approach are mostly based upon data derived from its largely known female counterpart. We aimed at investigating whether MBC cases harbor somatic alterations of genes known as prognostic biomarkers and molecular therapeutic targets in female breast cancer.We examined 103 MBC cases, all characterized for germ-line BRCA1/2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
